XORTX plans Health Canada clinical trial application for gout drug XORLO ahead of FDA filing

XORTX Therapeutics plans to submit a Health Canada clinical trial application for its gout drug XORLO ahead of a planned FDA filing.

Detected & updated continuously · Source: Nebula